SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?


To: billy d who wrote (4251)3/8/2000 4:20:00 AM
From: Ed Ajootian  Read Replies (1) | Respond to of 10280
 
Billy,

Very interesting that the stock closed right at the price at which the latest round of notes are convertible into stock. I feel folks just figure there are too many shares out on this turkey on a fully diluted basis at this point.

I also would bet that a lot of yesterday's selling was shorting against the box by the $63 noteholders, locking in a near double. Being in the age of computers and instantly available data, it amazes me that the stock exchanges can't make short interest data available more than once a month, and several weeks after the fact no less. Imagine how much better it would be if we had _daily reports of short interest. So today, we could find out that, say, SEPR short interest went up by 1 M shares yesterday, and the stock would pop right back up to where it was because folks would realize that all it was was some shorting against the box.

I believe another reason for the decline is the dearth of news recently on clinical progress by SEPR. Sure, they have initiated some important studies, but when was the last time they announced positive results of a drug study? I started looking back and gave up after about 4 months! They are supposedly spending all these millions of $$$ on clinical studies, so why isn't it generating some announceable news? I would expect a company this size to have something to put out at least once a month.